| 01/26 | Insider Sell: Danaher | MT |
| 01/26 | Raymond James Adjusts Intuitive Surgical's Price Target to $270 From $255, Keeps Outper.. | MT |
| 01/25 | Sector Update: Health Care Stocks Largely Sit Out Late Market Rebound | MT |
| 01/25 | Sector Update: Health Care Stocks Still Lacking Traction | MT |
| 01/25 | Sector Update: Health Care | MT |
| 01/25 | Wells Fargo Adjusts Price Target on Intuitive Surgical to $289 From $305, Maintains Ove.. | MT |
| 01/25 | Mizuho Adjusts Intuitive Surgical's Price Target to $240 From $245, Keeps Neutral Ratin.. | MT |
| 01/25 | Citigroup Adjusts Intuitive Surgical's Price Target to $305 From $318, Keeps Buy Rating | MT |
| 01/25 | BTIG Adjusts Intuitive Surgical's Price Target to $279 From $316, Keeps Buy Rating | MT |
| 01/25 | Deutsche Bank Adjusts Intuitive Surgical's Price Target to $245 From $230, Maintains Ho.. | MT |
| 01/25 | Cowen Adjusts Price Target on Danaher to $320 From $340, Maintains Outperform Rating | MT |
| 01/25 | Truist Securities Adjusts Price Target on Intuitive Surgical to $300 From $310, Maintai.. | MT |
| 01/25 | Sector Update: Health Care Stocks Mixed Premarket Wednesday | MT |
| 01/25 | RBC Cuts Price Target on Danaher to $289 From $293, Maintains Outperform Rating | MT |
| 01/24 | Intuitive Surgical Earnings Fall, Sales Increase in Q4 | MT |
| 01/24 | Transcript : Intuitive Surgical, Inc., Q4 2022 Earnings Call, Jan 24, 2023 | CI |
| 01/24 | Earnings Flash (ISRG) INTUITIVE SURGICAL Reports Q4 Revenue $1.66B | MT |
| 01/24 | Earnings Flash (ISRG) INTUITIVE SURGICAL Posts Q4 EPS $1.23 | MT |
| 01/24 | Tranche Update on Intuitive Surgical, Inc.'s Equity Buyback Plan announced on February .. | CI |
| 01/24 | Intuitive Surgical, Inc. Reports Earnings Results for the Full Year Ended December 31, .. | CI |
| 01/24 | Intuitive Surgical, Inc. Reports Earnings Results for the Fourth Quarter Ended December.. | CI |
| 01/24 | Danaher Fourth-Quarter Results Top Views; Cuts COVID-19-Related Revenue From Sales Grow.. | MT |
| 01/24 | Global markets live: GE, J&J, Verizon, Lockheed Martin, Halliburton... | |
| 01/24 | Mizuho Adjusts Price Target on Intuitive Surgical to $245 From $215, Maintains Neutral .. | MT |
| 01/24 | Sector Update: Health Care Stocks Flat to Lower Pre-Bell Tuesday | MT |
| 01/24 | Sector Update: Health Care | MT |
| 01/24 | Barclays Adjusts Danaher Price Target to $290 From $277, Maintains Overweight Rating | MT |
| 01/24 | Thermo Fisher Scientific Partners with AstraZeneca to Develop Solid Tissue and Blood-Ba.. | CI |
| 01/24 | Barclays Adjusts Thermo Fisher Scientific's Price Target to $630 From $570, Maintains O.. | MT |
| 01/24 | Danaher Seeks M&A | CI |
| 01/24 | Transcript : Danaher Corporation, Q4 2022 Earnings Call, Jan 24, 2023 | CI |
| 01/24 | Baird Adjusts Danaher's Price Target to $321 From $315, Maintains Outperform Rating | MT |
| 01/24 | Intuitive Surgical Firm in History of Adding to Post-Market Earnings Moves in Following.. | MT |
| 01/24 | Danaher Expects Core Sales Growth in 2023 | DJ |
| 01/24 | Danaher's Q4 Adjusted Earnings, Sales Increase; Issues Q1, 2023 Revenue Growth Outlook | MT |
| 01/24 | Danaher's 4Q Sales Rise, Driven by Life Sciences | DJ |
| 01/24 | Marketmind: Tech tonic, recession rethink | RE |
| 01/24 | Earnings Flash (DHR) DANAHER CORPORATION Reports Q4 EPS $2.87, vs. Street Est of $2.55 | MT |
| 01/24 | Danaher Corporation Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
| 01/24 | Danaher Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, .. | CI |
| 01/23 | Danaher 2023 Outlook Will Likely Surprise to Upside, RBC Says | MT |
| 01/23 | Thermo Fisher Scientific Inc. Launches CE-IVD Marked Assay to Detect Treatment-Resistan.. | CI |
| 01/19 | SetPoint Medical Corporation announced that it expects to receive $80 million in fundin.. | CI |
| 01/11 | Softening Inflation Expectations Push Equities Higher | MT |
| 01/11 | Softening Inflation Expectations Push Equities Higher | MT |
| 01/11 | Easing December Inflation Expectations Underpin US Equities | MT |
| 01/11 | Softer December Inflation Expectations Underpin US Equities | MT |
| 01/11 | Nasdaq Jumps 130 Points Ahead of December Inflation Report | MT |
| 01/11 | Intuitive Surgical Forecasts Fourth-Quarter Revenue Miss Amid COVID-19 Outbreak in Chin.. | MT |
| 01/11 | Transcript : Intuitive Surgical, Inc. Presents at 41st Annual J.P. Morgan Hea.. | CI |
| 01/11 | Transcript : Boston Scientific Corporation Presents at 41st Annual J.P. Morga.. | CI |
| 01/11 | Intuitive Surgical Sees 4Q Revenue Below Wall Street Expectations | DJ |
| 01/11 | Intuitive Surgical Expects 4% Decline In Q4 Revenue; Stock Slips Premarket | MT |
| 01/11 | Intuitive Surgical, Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year.. | CI |
| 01/10 | Transcript : Danaher Corporation Presents at 41st Annual J.P. Morgan Healthca.. | CI |
| 01/10 | Danaher Stock Rises 4% on Views for Higher 4Q Sales | DJ |
| 01/10 | Global markets live: Microsoft, Apple, Pfizer, Shell, Ford... | |
| 01/10 | Transcript : Thermo Fisher Scientific Inc. Presents at 41st Annual J.P. Morga.. | CI |
| 01/09 | Danaher Expects Better-Than-Projected Core Revenue Growth for Q4 | MT |
| 01/09 | Danaher Corporation Revises Revenue Guidance for the Fourth Quarter of 2022 | CI |
| 01/06 | SVB Securities Adjusts Thermo Fisher Scientific's Price Target to $620 From $555, Keeps.. | MT |
| 01/06 | Morgan Stanley Adjusts Price Target on Boston Scientific to $56 From $50, Maintains Ove.. | MT |
| 01/06 | Morgan Stanley Adjusts Price Target on Intuitive Surgical to $290 From $235, Maintains .. | MT |
| 01/06 | Thermo Fisher Scientific on Pace for Largest Percent Decrease Since November 2020 -- Da.. | DJ |
| 01/05 | UBS Adjusts Thermo Fisher Scientific Price Target to $648 From $630, Maintains Buy Rati.. | MT |
| 01/05 | Credit Suisse Downgrades Danaher to Neutral From Outperform, Says Pressure on Bioproces.. | MT |
| 01/05 | Proteome Sciences reaches "sales milestone" from contract | AN |
| 01/04 | Insider Sell: Boston Scientific | MT |
| 01/03 | Wells Fargo Adjusts Price Target on Thermo Fisher Scientific to $505 From $525, Maintai.. | MT |
| 01/03 | ASLAN Pharmaceuticals, Thermo Fisher Scientific to Produce Potential Antibody Eblasakim.. | MT |
| 01/03 | ASLAN Pharmaceuticals Limited and Thermo Fisher Scientific Inc. Announces Partnership t.. | CI |
| 01/03 | Acotec Scientific Sets Deadline to Accept HK$4 Billion Buyout Bid from NYSE-listed Bost.. | MT |
| 01/03 | Thermo Fisher Scientific Inc. completed the acquisition of The Binding Site Group Ltd. .. | CI |
| 2022 | Analyst recommendations: CarMax, Danaher, Next, Tesla... | |
| 2022 | Argus Research Adjusts Intuitive Surgical Price Target to $320 From $265, Maintains Buy.. | MT |
| 2022 | Mizuho Initiates Boston Scientific With Neutral Rating, Price Target is $52 | MT |
| 2022 | Citigroup Reinstates Boston Scientific at Buy With $54 Price Target | MT |
| 2022 | Truist Securities Adjusts Price Target on Boston Scientific to $54 From $50, Maintains .. | MT |
| 2022 | Truist Securities Adjusts Price Target on Intuitive Surgical to $310 From $300, Maintai.. | MT |
| 2022 | LBT Innovations Subsidiary Appoints Thermo Fisher as Exclusive Distributor for Europe | MT |
| 2022 | CCS Appoint Thermo Fisher as Exclusive European Distributor | CI |
| 2022 | Cancer researchers question antitrust arguments against Illumina-Grail deal | RE |
| 2022 | Transcript : Thermo Fisher Scientific Inc. - Special Call | CI |
| 2022 | Thermo Fisher Scientific's Monkeypox Test Receives Emergency Use Authorization From US .. | MT |
| 2022 | Insider Sell: Boston Scientific | MT |
| 2022 | FDA Grants Emergency Use Authorization for Thermo Fisher Scientific's Monkeypox Test | CI |
| 2022 | Deutsche Bank Initiates Coverage on Thermo Fisher Scientific With Buy Rating, $620 Pric.. | MT |
| 2022 | Deutsche Bank Initiates Coverage on Danaher With Buy Rating, $310 Price Target | MT |
| 2022 | Insider Sell: Boston Scientific | MT |
| 2022 | Insider Sell: Boston Scientific | MT |
| 2022 | Sector Update: Health Care Stocks Carried Higher with Broader Markets | MT |
| 2022 | Sector Update: Health Care Stocks Advancing on Monday | MT |
| 2022 | Wells Fargo Raises Price Target on Intuitive Surgical to $305 From $262, Maintains Over.. | MT |
| 2022 | Boston Scientific to Acquire Majority Stake in Acotec Scientific Holdings | MT |
| 2022 | Acotec Scientific Shares Rally as Boston Scientific Plans Stake Buy | DJ |
| 2022 | Raymond James Boosts Price Target on Boston Scientific to $54 From $48, Affirms Strong .. | MT |
| 2022 | RBC Initiates Thermo Fisher Scientific at Outperform With $660 Price Target, Cites 'Adv.. | MT |
| 2022 | Thermo Fisher Scientific Inc. Announces FDA Grants De Novo Classification to HLA Typing.. | CI |
| 2022 | Danaher Corporation Announces Quarterly Dividends, Payable on January 27, 2023 | CI |
| 2022 | Thermo Fisher Scientific Launches TrueMark Infectious Disease Research Panels | CI |
Google
Twitter
Facebook
Apple
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
